N🟁N

CryoPort Adds Senior Sales Director for Europe

  //house-home.news-articles.net/content/2011/09/1 .. oport-adds-senior-sales-director-for-europe.html
  Published in House and Home on Monday, September 12th 2011 at 5:16 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

SAN DIEGO--([ BUSINESS WIRE ])--CryoPort, Inc. (OTCBB: CYRX) today announced that Upinder Grewal has joined the Company as Senior Director of Sales for Europe. Mr. Grewal was previously with Quest Diagnostics in Europe for more than 13 years, serving in operations and logistics management.

"The appointment of Upinder Grewal reflects the important opportunity we see to expand our business in Europe and the Middle East"

aThe appointment of Upinder Grewal reflects the important opportunity we see to expand our business in Europe and the Middle East,a said Larry Stambaugh, CryoPorta™s Chairman and Chief Executive Officer. aUpindera™s tremendous experience in life science shipping and logistics, along with his extensive network of industry contacts, are a perfect combination for developing business in this market. This is just the first step in establishing a strong presence in Europe. Our near term plans also include setting up an European operations center to manage staging and recycling of our shipping containers and provide customer support.a

While at Quest Diagnostics, Mr. Grewal set up facilities and managed logistics in Europe, Asia and South America. In addition to negotiating and managing supplier contracts, he led strategic initiatives that resulted in significant shipping cost reductions and more efficient delivery processes.

About CryoPort, Inc.

CryoPort ([ www.cryoport.com ]) has developed a leading edge, proprietary, technology-driven transport and packaging system focused on providing a solution that replaces dry ice for the frozen shipping market in the growing global life science industry. The products developed by CryoPort have a 10+ day holding time, are using agreena materials and are essential components of the infrastructure required for the testing, research and end-user delivery of temperature-sensitive medicines and biomaterials in an increasingly complex global logistical environment.